D.E. Shaw & Co’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-127,610
Closed -$425K 3164
2023
Q4
$425K Sell
127,610
-578,798
-82% -$1.93M ﹤0.01% 2433
2023
Q3
$2.64M Sell
706,408
-430,740
-38% -$1.61M ﹤0.01% 1568
2023
Q2
$4.86M Buy
1,137,148
+138,770
+14% +$593K 0.01% 1262
2023
Q1
$6.83M Buy
998,378
+278,552
+39% +$1.91M 0.01% 1155
2022
Q4
$5.7M Buy
719,826
+124,282
+21% +$984K 0.01% 1365
2022
Q3
$5.72M Buy
595,544
+48,879
+9% +$470K 0.01% 1340
2022
Q2
$3.96M Buy
546,665
+180,878
+49% +$1.31M ﹤0.01% 1770
2022
Q1
$4.72M Buy
365,787
+270,122
+282% +$3.49M ﹤0.01% 1724
2021
Q4
$1.53M Buy
95,665
+50,998
+114% +$814K ﹤0.01% 2521
2021
Q3
$718K Sell
44,667
-50,195
-53% -$807K ﹤0.01% 2665
2021
Q2
$1.31M Sell
94,862
-174,771
-65% -$2.42M ﹤0.01% 2344
2021
Q1
$3.94M Sell
269,633
-13,937
-5% -$204K ﹤0.01% 1478
2020
Q4
$4.93M Sell
283,570
-303,064
-52% -$5.27M ﹤0.01% 1317
2020
Q3
$10.8M Sell
586,634
-253,885
-30% -$4.66M 0.01% 863
2020
Q2
$15M Sell
840,519
-601,624
-42% -$10.7M 0.02% 700
2020
Q1
$23.4M Buy
1,442,143
+337,631
+31% +$5.48M 0.04% 432
2019
Q4
$19.9M Buy
1,104,512
+726,647
+192% +$13.1M 0.02% 598
2019
Q3
$7.66M Buy
377,865
+124,142
+49% +$2.52M 0.01% 957
2019
Q2
$5.61M Sell
253,723
-52,551
-17% -$1.16M 0.01% 1118
2019
Q1
$4.18M Sell
306,274
-71,899
-19% -$981K 0.01% 1219
2018
Q4
$3.42M Buy
378,173
+91,848
+32% +$831K ﹤0.01% 1273
2018
Q3
$4.72M Buy
286,325
+177,142
+162% +$2.92M 0.01% 1152
2018
Q2
$1.53M Buy
109,183
+94,042
+621% +$1.32M ﹤0.01% 1714
2018
Q1
$167K Sell
15,141
-22,965
-60% -$253K ﹤0.01% 2395
2017
Q4
$336K Sell
38,106
-68,915
-64% -$608K ﹤0.01% 2243
2017
Q3
$1.43M Sell
107,021
-12,279
-10% -$164K ﹤0.01% 1630
2017
Q2
$1.71M Sell
119,300
-200,170
-63% -$2.87M ﹤0.01% 1497
2017
Q1
$6.76M Buy
319,470
+183,012
+134% +$3.87M 0.01% 839
2016
Q4
$3.84M Buy
136,458
+34,785
+34% +$979K 0.01% 1079
2016
Q3
$2.72M Buy
+101,673
New +$2.72M ﹤0.01% 1213